NCT05734846

Brief Summary

The purpose of this study was to compare the clinical performance of two fitting approaches for multifocal contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 11, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 9, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed
11 months until next milestone

Results Posted

Study results publicly available

January 10, 2024

Completed
Last Updated

January 10, 2024

Status Verified

February 1, 2023

Enrollment Period

2 months

First QC Date

February 9, 2023

Results QC Date

November 29, 2023

Last Update Submit

December 18, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Overall Vision Satisfaction

    Overall vision satisfaction for each lens was measured on a 0-100 point Visual Analog Scale (VAS), where 0=Extremely Unsatisfied and 100=Extremely Satisfied

    One week

  • Overall Lens Preference

    Participants selected their preferred lens fitting approach from options - 'Control', 'Test', or 'No Preference'

    Two weeks

Secondary Outcomes (2)

  • Overall Binocular Visual Acuity Index

    One week

  • Number of Contact Lenses

    One week

Study Arms (2)

Control Lenses, then Test Lenses

EXPERIMENTAL

Participants wore the Control Lenses for 1 week, then crossed over to the Test Lenses for 1 week.

Device: Control Lenses (control fitting approach)Device: Test Lenses (test fitting approach)

Test Lenses, then Control Lens

EXPERIMENTAL

Participants wore the Test Lenses for 1 week, then crossed over to the Control Lenses for 1 week.

Device: Control Lenses (control fitting approach)Device: Test Lenses (test fitting approach)

Interventions

Daily wear multifocal lenses for 1 week

Control Lenses, then Test LensesTest Lenses, then Control Lens

Daily wear multifocal lenses for 1 week

Control Lenses, then Test LensesTest Lenses, then Control Lens

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 40 years old;
  • Have read and understood the Participant Information Sheet;
  • Have read, signed and dated the Informed Consent;
  • Best corrected visual acuity of at least 20/25 in each eye;
  • Have normal eyes with the exception of the need for visual correction;
  • Current multifocal contact lens wearer;
  • Spectacle refraction:
  • Distance: Sphere: -6.00D to + 4.00D Astigmatism: 0.00D to -0.75D Near Addition: Established Presbyopes: +1.50D \& +1.75D
  • Be willing and able to adhere to the instructions set in the clinical protocol and maintain the appointment schedule.

You may not qualify if:

  • Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear;
  • Use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator;
  • Monocular participants (only one eye with functional vision) or participants fit with only one lens;
  • Any moderate or severe ocular condition observed during the slit-lamp examination at the enrolment visit;
  • History of herpetic keratitis, ocular surgery or irregular cornea;
  • Known pregnancy or lactation during the study period;
  • Enrolment of the investigator or his/her staff, family members of the investigator, family members of the investigator's staff, or individuals living in the households of these individuals.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ocular Technology Group - International

London, SW1E 6AU, United Kingdom

Location

MeSH Terms

Conditions

Presbyopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Percy Lazon de la Jara BOptom PhD
Organization
CooperVision Inc.

Study Officials

  • Michel Guillon, PhD, FCOptom

    Ocular Technology Group - International

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2023

First Posted

February 21, 2023

Study Start

October 11, 2022

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

January 10, 2024

Results First Posted

January 10, 2024

Record last verified: 2023-02

Locations